CD44 may also inhibit tumor progression by binding to high molecular weight hyaluronan and promote its interaction with hypophosphorylated Merlin, inhibit RAS activation, inhibit CD44–ERM interactions and suppress EGFR activation [63], [64]. This evidence concerns the gene CD44 and neoplasm.